ICP
TDOC icon

Interchange Capital Partners’s Teladoc Health TDOC Stock Holding History

Interchange Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,916
Closed -$180K – 290
2024
Q1 		$180K Sell
11,916
-975
-8% -$17.7K 0.12% 164
2023
Q4 		$277K Buy
12,891
+38
+0.3% +$701 0.21% 123
2023
Q3 		$239K Buy
12,853
+532
+4% +$12.4K 0.19% 131
2023
Q2 		$324K Buy
+12,321
New +$310K 0.25% 98
2022
Q4 		– Sell
-9,524
Closed -$241K – 159
2022
Q3 		$241K Sell
9,524
-871
-8% -$30.6K 0.26% 117
2022
Q2 		$345K Buy
10,395
+437
+4% +$18.6K 0.39% 82
2022
Q1 		$718K Buy
9,958
+3,204
+47% +$231K 0.74% 32
2021
Q4 		$620K Buy
+6,754
New +$807K 0.62% 44
2021
Q2 		– Sell
-5,584
Closed -$1.16M – 207
2021
Q1 		$1.16M Buy
5,584
+674
+14% +$156K 0.63% 41
2020
Q4 		$981K Buy
+4,910
New +$998K 0.53% 40

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Interchange Capital Partners's TDOC Position: Q2 2024 in Review

Interchange Capital Partners sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 11,916 shares — an estimated $180K sold.

Interchange Capital Partners first reported a position in TDOC in Q4 2020 and held it in 10 quarters. The position peaked at $1.16M in Q1 2021. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Interchange Capital Partners reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Interchange Capital Partners sold 11,916 Teladoc Health shares in Q2 2024, an estimated $180K.
  • Interchange Capital Partners first reported a position in Teladoc Health in Q4 2020 and held it in 10 quarters.
  • Interchange Capital Partners's Teladoc Health position peaked at $1.16M in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Interchange Capital Partners's 13F filing for Q2 2024, filed 31 Jul 2024.